A phase II randomized trial of docetaxel weekly or every 3 weeks in elderly and/or poor performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7057-7057 ◽  
Author(s):  
R. Lilenbaum ◽  
M. Rubin ◽  
J. Samuel ◽  
L. Boros ◽  
T. Chidiac ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Randomized Trial ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Performance Status ◽  
Poor Performance ◽  
Small Cell ◽  
Poor Performance Status ◽  
Small Cell Lung

scholarly journals Phase II Study of Docetaxel and Celecoxib, a Cyclooxygenase-2 Inhibitor, in Elderly or Poor Performance Status (PS2) Patients with Advanced Non-small Cell Lung Cancer

2008 ◽  
Vol 3 (11) ◽  
pp. 1293-1300 ◽  
Author(s):  
Shirish M. Gadgeel ◽  
Antoinette Wozniak ◽  
John C. Ruckdeschel ◽  
Lance K. Heilbrun ◽  
Raghu Venkatramanamoorthy ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Performance Status ◽  
Poor Performance ◽  
Small Cell ◽  
Poor Performance Status ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document